Article
Comparative Study of BBB-Targeting AAV Capsids on Central Nervous System Delivery Efficiency
2026-02-04
Abstract excerpt
<title>Abstract</title> <p> The efficacy of adeno-associated virus (AAV)-mediated systemic gene therapy for central nervous system (CNS) diseases is often limited by the blood-brain barrier (BBB). This study systematically evaluated the tissue distribution of three BBB-crossing AAV capsid variants (PHP.eB, CNSRCV300, and BI-hTFR1) following intravenous injection in mice, using either a constitutive promoter (CAG...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16181cbd-b11e-5eb5-89c4-9827b6908703
- DOI
- 10.21203/rs.3.rs-8716281/v1
